Evidence map›Paper›PMID 35234621›Full record

ArticleVirologica Sinica2022

Genomic surveillance of coxsackievirus A10 reveals genetic features and recent appearance of genogroup D in Shanghai, China, 2016-2020.

Jiayu Wang, Jiajing Liu, Fanghao Fang, Jiajin Wu, Tianjiao Ji, Yuying Yang, Ling Liu, Chongshan Li, Wanju Zhang, Xi Zhang and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Virologica Sinica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Current status of hand-foot-and-mouth disease.Journal of biomedical science · 2023
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Jiayu WangMicrobiology Department, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, 200336, China.
Jiajing LiuMicrobiology Department, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, 200336, China.
Fanghao FangMicrobiology Department, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, 200336, China.
Jiajin WuMicrobiology Department, Songjiang District Center for Disease Control and Prevention, Shanghai, 201620, China.
Tianjiao JiWHO WPRO Regional Polio Reference Laboratory, NHC Key Laboratory for Biosafety, NHC Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.
Yuying YangMicrobiology Department, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, 200336, China.
Ling LiuMicrobiology Department, Songjiang District Center for Disease Control and Prevention, Shanghai, 201620, China.
Chongshan LiMicrobiology Department, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, 200336, China.
Wanju ZhangMicrobiology Department, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, 200336, China. Electronic address: zhangwanju@scdc.sh.cn.
Xi ZhangMicrobiology Department, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, 200336, China. Electronic address: zhangxi@scdc.sh.cn.
Zheng TengMicrobiology Department, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, 200336, China. Electronic address: tengzheng@scdc.sh.cn.
Shanghai Municipal Center For Disease Control Prevention · CNSongjiang District Central Hospital · CNNational Institute for Viral Disease Control and Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coxsackievirus A10 (CVA10) is one of the major causative agents of hand, foot and mouth disease (HFMD). To investigate the epidemiological characteristics as well as genetic features of CVA10 currently circulating in Shanghai, China, we collected a total of 9,952 sporadic HFMD cases from January 2016 to December 2020. In the past five years, CVA10 was the fourth prevalent causatives associated with HFMD in Shanghai and the overall positive rate was 2.78%. The annual distribution experienced significant fluctuations over the past five years. In addition to entire VP1 sequencing, complete genome sequencing and recombination analysis of CVA10 isolates in Shanghai were further performed. A total of 64 near complete genomes and 11 entire VP1 sequences in this study combined with reference sequences publicly available were integrated into phylogenetic analysis. The CVA10 sequences in this study mainly belonged to genogroup C and presented 91%-100% nucleotide identity with other Chinese isolates based on VP1 region. For the first time, our study reported the appearance of CVA10 genogroup D in Chinese mainland, which had led to large-scale outbreaks in Europe previously. The recombination analysis showed the recombination break point located between 5,100 nt and 6,700 nt, which suggesting intertypic recombination with CVA16 genogroup D. To conclusion, CVA10 genogroup C was the predominant genogroup in Shanghai during 2016-2020. CVA10 recombinant genogroup D was firstly reported in circulating in Chinese mainland. Continuous surveillance is needed to better understand the evolution relationships and transmission pathways of CVA10 to help to guide disease control and prevention.

Indexed as

EnterovirusHand, Foot and Mouth DiseaseBenzeneacetamidesChinaGenomicsGenotypeHumansPhylogenyPiperidonesantineoplaston A10BenzeneacetamidesPiperidonesCoxsackievirus A10 (CVA10)Genogroup DHand, foot and mouth disease (HFMD)Intertypic recombination

Identifiers

PMID35234621
PMCPMC9170976
OpenAlexW4207042470

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.